Traders should anticipate reduced liquidity and potentially increased volatility following the reverse stock split. The move is typically aimed at meeting exchange listing requirements or improving market perception, but does not alter the company's fundamentals. Monitor trading volume and bid-ask spreads after April 27.
Price Chart
Executive Summary
Immunic, Inc. (IMUX) announced that shareholders approved a proposal to authorize the board to implement a reverse stock split at a ratio between 1-for-10 and 1-for-30. Following the vote, the board approved a 1-for-10 reverse stock split effective April 27, 2026. The new shares will trade under the same ticker IMUX with a new CUSIP.
Key Facts
- Shareholders approved a proposal authorizing the board to execute a reverse stock split within a range of 1-for-10 to 1-for-30.
- The board subsequently approved a 1-for-10 reverse stock split.
- The reverse stock split is expected to be effective at 12:01 a.m. Eastern Time on April 27, 2026.
- New shares will begin trading on the Nasdaq Capital Market on April 27, 2026 under the existing ticker symbol IMUX with a new CUSIP of 4525EP200.
- 57,404,749 votes were cast in favor, 12,594,555 against, and 623,363 abstained.
Financial Impact
The reverse stock split will reduce the number of outstanding shares by approximately 90% (1-for-10 ratio), increasing the per-share price proportionally without changing the company's market capitalization of $159M.
Risk Factors
- Potential for decreased trading liquidity due to fewer shares outstanding.
- Market perception of reverse splits as a sign of financial distress, despite no fundamental change.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193805-26-000461 |
| Document: 0001193805-26-000461-index-headers.html | 0001193805-26-000461 |
| Document: 0001193805-26-000461-index.html | 0001193805-26-000461 |
| Document: 0001193805-26-000461.txt | 0001193805-26-000461 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 6w ago | 8-K | $12.19 | awaiting T+60 | — | $7.49 (−38.60%) |
Aug 11, 2026 11w ago | 8-K | $15.48 | awaiting T+60 | — | $7.49 (−51.65%) |
Jul 14, 2026 15w ago | 8-K | $14.69 $7.63 | ▼ −48.06% | ▼ −51.44% | $7.49 (−49.05%) |
Jun 29, 2026 17w ago | 8-K | $15.37 $9.37 | ▼ −39.04% | ▼ −42.60% | $7.49 (−51.30%) |
May 19, 2026 22w ago | 3 | $11.55 $16.06 | ▲ +39.05% | ▲ +34.04% | $7.49 (−35.19%) |
May 19, 2026 23w ago | 8-K | $11.60 $16.58 | ▲ +42.93% | ▲ +36.64% | $7.49 (−35.47%) |
Apr 30, 2026 25w ago | S-3/A | $9.65 $13.34 | ▼ −38.24% | ▼ −35.17% | $7.49 (+22.44%) |
Apr 23, 2026 26w ago | 8-K | $9.18 $15.00 | ▲ +63.40% | ▲ +58.38% | $7.49 (−18.46%) |
Apr 14, 2026 27w ago | 8-K | $11.10 $14.77 | ▲ +33.06% | ▲ +24.93% | $7.49 (−32.57%) |
Apr 10, 2026 28w ago | 8-K | $12.20 $14.77 | ▲ +21.07% | ▲ +12.14% | $7.49 (−38.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers